It looks like the email we have in your account is invalid. Please update this to complete the sign-up process.

It looks like the email we have in your account is invalid.

Looks like your email is invalid.

Update email

Would you like to receive DramaFever news and exclusive promotions?

Would you like to receive DramaFever news and exclusive promotions?

Would you like to receive DramaFever promotions?

Would you like to try our new layout?

Would you like to try our new layout?

Would you like to try our new layout?

Yes! No, Don't ask me again

Please disable compatibility mode to improve your experience.

Our website may look like a mismatched Mr. Potato Head with it turned on.

Click here to learn how

It looks like you don't have Adobe Flash Player installed.

Without it, your DramaFever experience will be like watching TV with blindfolds on.

Click here to download and install

Your browser is on the brink of extinction.

Try one of these awesome modern browsers to fully take advantage of all that DramaFever has to offer!

Click here to download and install

Biography

David Zepeda is a Mexican actor and model born in Nogales on September 19th, 1973. He graduated in Law from the Unversidad de Sonora and then in acting from the Centro de Formación Actoral from TV Azteca. He then represented Mexico in the contest called Manhunt International 2000, reaching second place. In 2009, he landed the role of antagonist in the production Sortilegio de Carla Estrada along with Jacqueline Bracamontes and William Levy.

In 2010, David Zepeda acted in the telenovela Soy Tu Dueña, where he played the role of antagonist along with Lucero and Fernando Colunga. Later on David interpreted Ricardo Cordero in Perfume de Gardenias along with Aracely Arámbula. Then in 2011, David Zepeda became the image of the campaign Déjate Ver for Calvin Klein, an underwear company. He then landed the front page of the magazine Men’s Health. His most recent work has been in Abismo de Pasión.

Recently In

Latest Casting News
Show all

Post a New Comment

Please sign in to comment.

Discussion